Glaxosmithkline Share News (GSK)

Ex-divs to take 14 points off FTSE 100 on Wednesday

LONDON, Feb 17 (Reuters) - The following FTSE 100 companies will go ex-dividend on Wednesday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-

Berkshire Hathaway unloads position in GlaxoSmithKline

Berkshire Hathaway, billionaire investor Warren Buffet's investment vehicle, unloaded its stake in GlaxoSmithKline during the fourth quarter of 2013, according to the US Securities and Exchange Commission (SEC). Previously, as of September 30th of 2013, Berkshire Hathaway held 1.511m shares in the

DIRECTOR DEALINGS: GlaxoSmithKline Executives Share Awards Vest

LONDON (Alliance News) - GlaxoSmithKline PLC Friday announced that a group of executives, including Chief Executive Officer Andrew Witty, had received shares after share options they had been awarded had vested.

The following executives share options from the company's 2011 performa

UK Dividends Calendar - Week Ahead

Read more 14 Feb 2014 13:06 UK MIDDAY BRIEFING: Lloyds Appoints TSB Chairman Ahead Of London Listing LONDON (Alliance News) - Lloyds Banking Group has appointed Will Samuel, a former Citi investment banker and adviser to one of the UK financial services regulators, as Chairman of TSB Bank, the bank it split out as a separate entity last year and is expected to list this year. Read more 14 Feb 2014 10:10 UK BROKER RATINGS: Six Brokers Cut Tate & Lyle Price Target LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning: ---------- FTSE 100 ---------- JPMORGAN RAISES LLOYDS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 95 (84) PENCE ---------- SOCGEN RAISES LLOYDS PRICE TARGE Read more 14 Feb 2014 06:29 UK Dividends Calendar - Week Ahead Read more 13 Feb 2014 16:12 UK Dividends Calendar - Week Ahead Read more 13 Feb 2014 12:00 Vectura Says Performing In Line With Expectations LONDON (Alliance News) - Vectura Group PLC said Thursday that its performance in the period from October 1, 2013 to date had been in line with expectations. During the period Vectura's partner Sandoz saw marketing authorisation for AirFluSal Forspiro, an inhaler for asthma or Chronic Obstru Read more 13 Feb 2014 06:15 UK Dividends Calendar - Week Ahead Read more 284285286287288289290291292 Stay Informed! With our newsletters and social media channels. Daily Market Report (Weekday Evenings)Week Ahead (Sunday Evening) Login to your account Login failed Remember MeSign In Don't have an account? Click here to register. Quickpicks are a member only feature Login to your account Login failed Remember MeSign In Don't have an account? Click here to register.